• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌的新辅助治疗——术前肿瘤活检的生物样本库建设

Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies.

作者信息

Jo Peter, Nietert Manuel, Gusky Linda, Kitz Julia, Conradi Lena C, Müller-Dornieden Annegret, Schüler Philipp, Wolff Hendrik A, Rüschoff Josef, Ströbel Philipp, Grade Marian, Liersch Torsten, Beißbarth Tim, Ghadimi Michael B, Sax Ulrich, Gaedcke Jochen

机构信息

Department of General, Visceral and Pediatric Surgery, University Medical Center, Goettingen, Germany.

Department of Medical Statistics, University Medical Center, Goettingen, Germany.

出版信息

Sci Rep. 2016 Oct 18;6:35589. doi: 10.1038/srep35589.

DOI:10.1038/srep35589
PMID:27752113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5067705/
Abstract

Translational research relies on high-quality biospecimens. In patients with rectal cancer treated preoperatively with radiochemotherapy tissue based analyses are challenging. To assess quality challenges we analyzed tissue samples taken over the last years in a multicenter setting. We retrospectively evaluated overall 197 patients of the CAO/ARO/AIO-94- and 04-trial with locally advanced rectal cancer that were biopsied preoperatively at the University Medical Center Goettingen as well as in 10 cooperating hospitals in Germany. The cellular content of tumor, mucosa, stroma, necrosis and the amount of isolated DNA and RNA as well as the RNA integrity number (RIN) as quality parameters were evaluated. A high RNA yield (p = 2.75e-07) and the content of tumor (p = 0.004) is significantly associated to high RIN-values, whereas a high content of mucosa (p = 0.07) shows a trend and a high amount of necrosis (p = 0.01) is significantly associated with RNA of poor quality. Correlating biopsies from Goettingen and the cooperating centers showed comparable tumor content results. By taking small sized biopsies we could assess a clear correlation between a good RNA quality and a high amount of RNA and tumor cells. These results also indicate that specimens collected at different centers are of comparable quality.

摘要

转化研究依赖于高质量的生物样本。对于术前接受放化疗的直肠癌患者,基于组织的分析具有挑战性。为了评估质量挑战,我们在多中心环境中分析了过去几年采集的组织样本。我们回顾性评估了CAO/ARO/AIO-94和04试验中总共197例局部晚期直肠癌患者,这些患者在哥廷根大学医学中心以及德国10家合作医院接受了术前活检。评估了肿瘤、黏膜、基质、坏死的细胞含量以及分离的DNA和RNA的量,以及作为质量参数的RNA完整性数值(RIN)。高RNA产量(p = 2.75e-07)和肿瘤含量(p = 0.004)与高RIN值显著相关,而高黏膜含量(p = 0.07)呈现出一种趋势,高坏死量(p = 0.01)与质量较差的RNA显著相关。对哥廷根和合作中心的相关活检进行比较,结果显示肿瘤含量结果具有可比性。通过采集小尺寸活检样本,我们能够评估良好的RNA质量与高RNA量和肿瘤细胞之间的明确相关性。这些结果还表明,在不同中心采集的样本质量具有可比性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/defb704d8512/srep35589-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/342943d7caf6/srep35589-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/566d22c7f6ea/srep35589-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/e6c342eb7db1/srep35589-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/86fd086ec839/srep35589-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/baf4e483622d/srep35589-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/26f3e1612d9d/srep35589-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/defb704d8512/srep35589-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/342943d7caf6/srep35589-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/566d22c7f6ea/srep35589-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/e6c342eb7db1/srep35589-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/86fd086ec839/srep35589-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/baf4e483622d/srep35589-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/26f3e1612d9d/srep35589-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de63/5067705/defb704d8512/srep35589-f7.jpg

相似文献

1
Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies.直肠癌的新辅助治疗——术前肿瘤活检的生物样本库建设
Sci Rep. 2016 Oct 18;6:35589. doi: 10.1038/srep35589.
2
Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.术前放化疗后直肠癌患者淋巴结转移的分期相关频率:CAO/ARO/AIO-94试验结果及广泛病理检查的比较前瞻性评估结果
Dis Colon Rectum. 2016 May;59(5):377-85. doi: 10.1097/DCR.0000000000000570.
3
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.奥沙利铂联合氟尿嘧啶为基础的术前放化疗和局部进展期直肠癌术后化疗(德国 CAO/ARO/AIO-04 研究):多中心、开放标签、随机、III 期临床试验的最终结果。
Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.
4
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.局部进展期直肠癌术前放化疗后肿瘤退缩分级的再评价:CAO/ARO/AIO-94 研究的更新结果。
J Clin Oncol. 2014 May 20;32(15):1554-62. doi: 10.1200/JCO.2013.54.3769. Epub 2014 Apr 21.
5
[Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].新辅助放化疗后ypT1/2期直肠癌的淋巴结转移:保器官手术的致命弱点?
Chirurg. 2016 Jul;87(7):593-601. doi: 10.1007/s00104-016-0170-9.
6
The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.组织诊断在局部晚期直肠癌新辅助放化疗前的作用。
Colorectal Dis. 2014 Oct;16(10):783-7. doi: 10.1111/codi.12653.
7
Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.直肠癌术前放化疗后淋巴结转移:直肠内分布和残留微转移受累的影响。
Am J Surg Pathol. 2013 Aug;37(8):1283-9. doi: 10.1097/PAS.0b013e3182886ced.
8
Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.术前放化疗治疗的直肠癌中 CD133 表达细胞的富集是转移和生存的独立标志物。
Cancer. 2013 Jan 1;119(1):26-35. doi: 10.1002/cncr.27703. Epub 2012 Jun 26.
9
Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients.生长模式与肿瘤退缩的联合可识别接受新辅助治疗的直肠癌患者中的高危组。
J Dig Dis. 2017 May;18(5):283-291. doi: 10.1111/1751-2980.12471.
10
Multicenter fresh frozen tissue sampling in colorectal cancer: does the quality meet the standards for state of the art biomarker research?结直肠癌多中心新鲜冷冻组织采样:其质量是否符合前沿生物标志物研究的标准?
Cell Tissue Bank. 2017 Sep;18(3):425-431. doi: 10.1007/s10561-017-9613-x. Epub 2017 Mar 3.

引用本文的文献

1
A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens.一项使用细胞学标本进行肺癌基因检测板检测的前瞻性验证研究。
Cancers (Basel). 2022 Aug 3;14(15):3784. doi: 10.3390/cancers14153784.
2
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy.治疗前活检的基因表达谱可预测直肠癌患者对术前放化疗的完全缓解反应。
Br J Cancer. 2022 Sep;127(4):766-775. doi: 10.1038/s41416-022-01842-2. Epub 2022 May 21.
3
Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo.

本文引用的文献

1
Architecture of a Biomedical Informatics Research Data Management Pipeline.生物医学信息学研究数据管理管道架构
Stud Health Technol Inform. 2016;228:262-6.
2
Integrated Data Repository Toolkit (IDRT). A Suite of Programs to Facilitate Health Analytics on Heterogeneous Medical Data.集成数据存储库工具包(IDRT)。一套用于促进对异构医学数据进行健康分析的程序。
Methods Inf Med. 2016;55(2):125-35. doi: 10.3414/ME15-01-0082. Epub 2015 Nov 4.
3
Improving IT-Support for Biobank Users.
Stud Health Technol Inform. 2014;202:197-200.
新型PFKFB3抑制剂KAN0438757对大肠癌细胞的作用及其体内系统毒性评价
Cancers (Basel). 2021 Feb 28;13(5):1011. doi: 10.3390/cancers13051011.
4
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.直肠癌患者原发肿瘤与相应转移灶 KRAS 突变状态的一致性。
PLoS One. 2020 Oct 1;15(10):e0239806. doi: 10.1371/journal.pone.0239806. eCollection 2020.
5
Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.直肠癌患者放化疗期间血浆中微小RNA水平的变化
Int J Mol Sci. 2017 May 27;18(6):1140. doi: 10.3390/ijms18061140.
4
How to design biospecimen identifiers and integrate relevant functionalities into your biospecimen management system.如何设计生物样本标识符并将相关功能集成到您的生物样本管理系统中。
Biopreserv Biobank. 2014 Jun;12(3):199-205. doi: 10.1089/bio.2013.0085.
5
Developing translational research infrastructure and capabilities associated with cancer clinical trials.发展与癌症临床试验相关的转化研究基础设施和能力。
Expert Rev Mol Med. 2013 Sep 27;15:e11. doi: 10.1017/erm.2013.12.
6
Use of research biopsies in clinical trials: are risks and benefits adequately discussed?临床研究中使用研究活检:风险和获益是否得到充分讨论?
J Clin Oncol. 2013 Jan 1;31(1):17-22. doi: 10.1200/JCO.2012.43.1718. Epub 2012 Nov 5.
7
Preoperative chemoradiotherapy for esophageal or junctional cancer.术前放化疗治疗食管或食管胃交界癌。
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
8
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.局部进展期直肠癌的术前放化疗和术后氟尿嘧啶与奥沙利铂联合化疗与单纯氟尿嘧啶化疗的比较:德国 CAO/ARO/AIO-04 随机 3 期临床试验的初步结果。
Lancet Oncol. 2012 Jul;13(7):679-87. doi: 10.1016/S1470-2045(12)70187-0. Epub 2012 May 23.
9
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.局部进展期直肠癌术前与术后放化疗的比较:中位随访 11 年后德国 CAO/ARO/AIO-94 随机 III 期临床试验结果。
J Clin Oncol. 2012 Jun 1;30(16):1926-33. doi: 10.1200/JCO.2011.40.1836. Epub 2012 Apr 23.
10
Quantifying histological features of cancer biospecimens for biobanking quality assurance using automated morphometric pattern recognition image analysis algorithms.使用自动形态计量模式识别图像分析算法对癌症生物样本的组织学特征进行量化,以确保生物样本库的质量。
J Biomol Tech. 2011 Sep;22(3):108-18.